Vipul Life Science

Mumbai, India Founded: 2003 • Age: 23 yrs
Delivers comprehensive drug development services to support pharmaceutical innovation.

About Vipul Life Science

Vipul Life Science is a Healthcare company based in Mumbai (India) founded in 2003. It delivers comprehensive drug development services to support pharmaceutical innovation. It operates on a B2B model. Its Indian entity Vipul Life Science Limited reported revenue of β‚Ή81.62 Cr. Its focus areas include Pharmaceuticals, Drug Development and Service Solutions.

Company details

Vipul Life Science delivers comprehensive drug development services to support pharmaceutical innovation through providing healthcare solutions, producing pharmaceutical products, drug development, and service solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹81.62 Cr

    FY 2025 · +25% YoY

  • Net Profit
    ₹1.81 Cr

    FY 2025 · 2% margin

  • EBITDA
    ₹3.53 Cr

    FY 2025 · 4% margin

Board of directors of Vipul Life Science Limited (Vipul Life Science)

Vipul Life Science Limited is the primary company behind Vipul Life Science. The boards of the 2 registered companies of Vipul Life Science currently have 6 directors; the longest-serving is Sunilkumar Sureshkumar Sheth, appointed in 2003. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sunilkumar Sureshkumar Sheth
DIN 01356340
Managing Director30 Sep 200323 yrs 1 moVipul Life Science Limited
Vipul Suresh Sheth
DIN 01570125
Whole-time director30 Sep 200323 yrs 1 moVipul Life Science Limited
Chandreshkumar B Roy
DIN 08521309
Designated Partner26 Jul 20197 yrs 3 moAvaco Research & Development Llp
Pankaj Madhukumar Doshi
DIN 06616186
Designated Partner26 Jul 20197 yrs 3 moAvaco Research & Development Llp
Vipul Kishorebhai Gondhiya
DIN 00009182
Director17 Dec 20223 yrs 11 moVipul Life Science Limited
Nimesh Anantrai Sheth
DIN 07023088
Director08 Nov 20242 yrsVipul Life Science Limited

Financials of Vipul Life Science

Figures of Vipul Life Science Limited, the primary company behind Vipul Life Science, for FY 2025. Revenue was ₹81.62 Cr (+25% year on year). Net profit was ₹1.81 Cr (2% margin). EBITDA was ₹3.53 Cr (4% margin). Revenue has grown at a compounded annual rate of -17% over three years and +11% over five years.

  • ₹81.62 CrRevenue · FY 2025 · +25% YoY
  • ₹1.81 CrNet profit · 2% margin
  • ₹3.53 CrEBITDA · 4% margin
  • ₹1.36 CrPaid-up capital
  • -17%Revenue CAGR, 3 years
  • +11%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Vipul Life Science Limited are on its company page.

Premium access

Detailed financial statements for Vipul Life Science

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Vipul Life Science

Vipul Life Science was founded in 2003.

Vipul Life Science is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

The primary company behind Vipul Life Science, Vipul Life Science Limited, reported revenue of β‚Ή81.62 Cr for FY 2025, up 25% year on year.

Vipul Life Science delivers comprehensive drug development services to support pharmaceutical innovation through providing healthcare solutions, producing pharmaceutical products, drug development, and service solutions. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Vipul Life Science is associated with 2 legal entities: Vipul Life Science Limited, Avaco Research & Development Llp.

The legal entities of Vipul Life Science currently have 6 directors, including Chandreshkumar B Roy, Pankaj Madhukumar Doshi, Sunilkumar Sureshkumar Sheth and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available